Core Scientific, Inc. CORZ Accrued customer funded construction

Other financials

Revenue$115.2M+44.9%

Gross profit$30.1M+267%

Operating income-$310.4M-560%

Net income-$347.2M-160%

EPS (diluted)-$1.06-185%

Cash & equivalents$1.1B+64.0%

Total debt$2.2B+82.8%

Total equity-$1.3B-323%

Total assets$3.1B+88.9%

Operating cash flow$249.9M+655%

CapEx$389.2M+363%

Free cash flow-$139.3M-8.0%

Market cap$9.27B+121%

Enterprise value$10.28B+119%

P/S26.1×+15.9×

Gross margin16.9%+4.3pp

Operating margin-144.7%-478pp

Net margin-238.9%-1.8pp

FCF margin-130%-246pp

Return on equity-242.4%—

Debt / equity2.2×—

Current ratio0.5×-3.7×

Reported directly by Core Scientific, Inc. in its filing.

Tagged under the XBRL concept core:AccruedCustomerFundedConstructionCurrent.

The official record: Core Scientific, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Connect your AI assistant and see it in context, right in your chat.

What is Core Scientific, Inc.'s accrued customer funded construction?: Core Scientific, Inc. (CORZ) reported accrued customer funded construction of $193.67M in Q1 2026.